Scale -


  • Ebitda is 6.94 Rs Cr; Annual Growth is 19 %; Continuous Growth over 3 years; 5 Year CAGR is 42 %
  • PBT is N/A Rs Cr; Annual Growth is 40 %; 5 Year CAGR is 86 %
  • PAT is 4.12 Rs Cr; Annual Growth is 46 %; Continuous Growth over 3 years; 5 Year CAGR is 88 %
  • Revenue is 31.2 Rs Cr; Continuous Growth over 3 years

Profitability -


  • PAT Margin is 13.19 %; Annual Growth is 31 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 76 %
  • PBDIT Margin is 22.24 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 33 %

Return -


  • ROA is 14.26 %; Annual Growth is 32 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 72 %
  • ROCE is 39.98 %; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 33 %
  • ROE is 33.08 %; in Top Quartile; 5 Year CAGR is 50 %
  • Asset Turnover is 113 %; in Top Quartile

Efficiency -


  • Current Ratio is 2.15; Continuous Growth over 3 years
  • Quick Ratio is 1.64; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 4.8; Continuous Growth over 3 years

Solvancy -


  • Debt/Equity is 0.74; Annual Decline is -43 %; Continuous Decline over 3 years; 5 Year CAGR is -22 %; in Top Quartile
  • Long term Debt is 1.46 Rs Cr; Annual Decline is -54 %; Continuous Decline over 3 years; 5 Year CAGR is -29 %
  • Total Debt is 9.16 Rs Cr; Continuous Decline over 3 years
  • Contingent Liabilities is 3.37 Rs Cr; Annual Growth is 338 %; Continuous Growth over 3 years; in Top Quartile

Quality -


  • Current Tax/PAT is 35 %; Continuous Decline over 3 years
  • Other Expenses/Total Expenses is 23 %; Continuous Decline over 3 years; in Top Quartile; 5 Year CAGR is 36 %
  • Operating cashflow/PAT is 68 %; Continuous Decline over 3 years
  • Exceptional Items/PBT is 0 %; in Top Quartile
  • Change in Inventories/Total Expenses is 2 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem


Sector
Major Subsidiaries/Associates
Key Clients

Products


Products
Product details

Operations


Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Compare PRIYA. with
Goldline Pharmaceutical Ltd. Estimates – BSE:GLPL
GOLDLINE PHARMACEUTICAL LIMITE Share Price
Goldline Pharmaceutical Ltd. Financials | 544759